Mumbai
Today, IPOs of three companies were listed on the main board of the stock market (IPO Listing Today). Among them were shares of Vishal Megamart, Mobikwik and Sai Life Sciences. Among these, investors made the highest profit in the shares of MobiKwik. Its shares were listed on BSE at a premium of 58.51 percent. The listing of investors of Vishal Megamart was also fine. Its shares were listed in BSE with a return of 41 percent. Shares of Sai Life Sciences were also listed on BSE at a premium of 20 percent.
How was the listing of Vishal Megamart?
Vishal Megamart shares were listed at Rs 110 on BSE with a gain of 41 per cent. Its share was allotted at Rs 78. That means an increase of Rs 32 on every share. But due to profit booking, it fell to Rs 104.92 within some time. It is noteworthy that the Rs 8,000 crore IPO of supermarket giant Vishal Mega Mart was opened on December 11. The company’s IPO closed on December 13. In this, anchor investors had bid on 10 December. No fresh shares were issued in this IPO. This was a complete Offer for Sale (OFS). The shares have been sold by the company’s promoter Samyat Services LLP. He holds 96.55% stake in the company. The company had fixed the price band at Rs 74-78 for a share with a face value of Rs 10.
What was the condition of MobiKwik?
MobiKwik shares were listed at Rs 442.25 in BSE. Investors got this share for Rs 279. This means that investors earned Rs 163.25 or 58.51 percent on the very first day. It is noteworthy that investors got the opportunity to bid in the IPO of One Mobikwik Systems Ltd, which provides wallet and some other services, from December 11 to December 13. During this period, huge response was received from investors. Mobikwik IPO was offered in a lot size of 53 shares and price band of ₹265-₹279. On the last day of bidding, the company had received bids for a total of 1,41,72,86,992 shares against 1,18,71,696 shares. Meaning that this IPO was oversubscribed 119.38 times.
Good earnings in Sai Life Sciences also
The IPO of Sai Life Sciences, a company developing and manufacturing small-molecule new chemical entities (NCEs), was also listed with a premium of 20 percent. Its one share was bought for Rs 549. Whereas it was listed in BSE at Rs 660, which means its IPO was held on 11 December. The company raised Rs 3043 crore through offer for sale till December 13, while a fresh issue of Rs 900 crore was issued. The price band of Life Sciences IPO was fixed at Rs 522 to Rs 549 per share.
